New insider activity at AptarGroup ( (ATR) ) has taken place on February 19, 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Segment President Gael Touya has executed a notable insider transaction in AptarGroup stock, selling 3,500 shares for a total value of $494,725. This move highlights recent insider activity at the company, with nearly half a million dollars’ worth of AptarGroup stock changing hands in a single transaction.
Recent Updates on ATR stock
AptarGroup shares reacted to a mixed Q4 update showing strong top-line growth, especially in Pharma injectables and Beauty, but with notable margin compression from emergency medicine destocking, higher production costs, and heavier low-margin tooling. BofA’s revised target reflects trimmed 2026 estimates and updated valuation on this lower near-term earnings base, while Baird’s higher target follows improved earnings visibility and a more constructive view on the company’s Pharma-led growth and productivity-driven margin recovery, supported by solid cash generation and buybacks.
Spark’s Take on ATR Stock
According to Spark, TipRanks’ AI Analyst, ATR is a Outperform.
The score is driven primarily by strong underlying financial performance (steady growth, solid margins, and manageable leverage). This is supported by generally positive near-term technical momentum, while a mid-range valuation and a balanced earnings-call outlook—strong pipeline and buybacks offset by near-term margin/EPS headwinds—keep the overall score in the mid-70s.
To see Spark’s full report on ATR stock, click here.
More about AptarGroup
YTD Price Performance: 16.65%
Average Trading Volume: 538,954
Technical Sentiment Signal: Buy
Current Market Cap: $9.12B